INCY:NASDAQ
Incyte Corp
115,13 $
arrow_downward
-1,72%(-2,01) 1D
2 қаз., 13:23:52 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
116,76 $
High
117,19 $
Low
115,13 $
Mkt. cap
23,34 млрд
Avg. vol.
1,45 млн
Volume
678,97 м.
P/E ratio
14,67
52-wk high
132,60 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,74
Shares outstanding
202,70 млн
No. of employees
3 мың
Open
116,76 $
High
117,19 $
Low
115,13 $
Mkt. cap
23,34 млрд
Avg. vol.
1,45 млн
Volume
678,97 м.
P/E ratio
14,67
52-wk high
132,60 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,74
Shares outstanding
202,70 млн
No. of employees
3 мың
News stories
From web sources and news partners
Stock Traders Daily
·
9 сағат бұрын
Avoiding Lag: Real-Time Signals in (INCY) Movement
Benzinga
·
19 сағат бұрын
If You Invested $1000 In Incyte Stock 20 Years Ago, You Would Have This Much Today
GuruFocus
·
1 күн бұрын
INCY Maintained by Wells Fargo -- Price Target Raised to $128
AD HOC NEWS
·
1 күн бұрын
Incyte presents EADV data for Incyte stock
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2,84 мың
Founded2002
HeadquartersWilmington, Делавэр, Америка Құрама Штаттары
Sector-
Websiteincyte.com